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Introduction
RNA-guided endonucleases of the CRISPR-Cas system, such as Cas9 (1) and Cpf1 (also known as Cas12a) (2) , have proven to be versatile tools for genome editing and regulation (3), which have numerous implications in medicine, agriculture, bioenergy, food security, nanotechnology, and beyond (4) . The range of targetable sequences is limited, however, by the need for a specific protospacer adjacent motif (PAM), which is determined by DNA-protein interactions, to immediately follow the DNA sequence specified by the single guide RNA (sgRNA) (1, (5) (6) (7) (8) . For example, the most widely used variant, Streptococcus pyogenes Cas9 (SpCas9), requires an 5'-NGG-3' motif downstream of its RNA-programmed DNA target (1, (4) (5) (6) (7) (8) . To relax this constraint, additional Cas9 and Cpf1 variants with distinct PAM requirements have been either discovered (9-13) or engineered (12) (13) (14) (15) to diversify the range of targetable DNA sequences. In total, these studies have provided only a handful of CRISPR effectors with minimal PAM requirements that enable wide targeting capabilities.
To help augment this list, we characterize an orthologous Cas9 protein from Streptococcus canis, ScCas9 (UniProt I7QXF2), possessing 89.2% sequence similarity to SpCas9.
We find that despite such homology, ScCas9 prefers a non-canonical 5'-NNGT-3' PAM. To explain this divergence, we identify two significant insertions within its open reading frame (ORF) that differentiate ScCas9 from SpCas9 and contribute to its PAM-recognition flexibility. We show that ScCas9 can efficiently edit genomic DNA in mammalian cells, and construct a bioinformatics pipeline to explore the PAM specificities of other Streptococcus orthologs. Finally, we investigate possible explanations for PAM divergence between Streptococcus orthologs by combining our engineering and bioinformatics approaches.
Results

Identification of SpCas9 Homologs
While numerous Cas9 homologs have been sequenced, only a handful of Streptococcus orthologs have been characterized or functionally validated. To explore this space, we curated all Streptococcus Cas9 protein sequences from UniProt (16), performed global pairwise alignments using the BLOSUM62 scoring matrix (17) , and calculated percent sequence homology to SpCas9. From them, the Cas9 from Streptococcus canis (ScCas9) stood out, not only due to its remarkable sequence homology (89.2%) to SpCas9, but also because of a positive-charged insertion of 10 amino acids within the highly-conserved REC3 domain, in positions 367-376 ( Figure 1A ). Exploiting both of these properties, we modeled the insertion within the corresponding domain of PDB 4OO8 (18) and, when viewed in PyMol, noticed that it formed a "loop"-like structure, of which several of its positive-charged residues come in close proximity with the target DNA near the PAM ( Figure 1B) . We further identified an additional insertion of two amino acids (KQ) immediately upstream of the two critical arginine residues necessary for PAM binding (19) , in positions 1337-1338 ( Figure 1A ). We thus hypothesized that these insertions may affect the PAM specificity of this enzyme. To support this prediction, we computationally characterized the PAM for ScCas9, by first mapping spacer sequences from the Cas9-associated type II CRISPR loci in the Streptococcus canis genome (20) to viral and plasmid genomes using BLAST (21) , extracting the sequences 3' to the mapped protospacers, and subsequently generating a WebLogo (22) representation of the aligned PAM sequences. Our analysis suggested an 5'-NNGTT-3' PAM ( Figure 1C ). Intrigued by these novel motifs and motivated by its predicted, divergent PAM, we selected ScCas9 as a candidate for further PAM characterization and engineering.
Determination of PAM Sequences Recognized by ScCas9
Due to the the relatively low number of protospacer targets, we validated the PAM binding sequence of ScCas9 utilizing an existent positive selection bacterial screen based on GFP expression conditioned on PAM binding, termed PAM-SCANR (23) . A plasmid library containing the target sequence followed by a randomized 5'-CNNNNC-3' PAM sequence was bound by a nuclease-deficient ScCas9 (and dSpCas9 as a control) and an sgRNA both specific to the target sequence and general for SpCas9 and ScCas9, allowing for the repression of lacI and expression of GFP. Plasmid DNA from FACS-sorted GFP-positive cells and pre-sorted cells were extracted and amplified, and enriched PAM sequences were identified by Sanger sequencing. Our results provide initial evidence that ScCas9 can bind to a more minimal 5'-NNGT-3' PAM, distinct to that of SpCas9's 5'-NGG-3' (Figure 2A ).
We hypothesized that the previously described insertions may contribute to this flexibility, and thus engineered ScCas9 to remove either insertion or both, and subjected these variants to the same screen. Only removing the loop (ScCas9 ∆367-376 or ScCas9 ∆Loop) extended the PAM of ScCas9 to 5'-NAGT-3', while only removing the KQ insertion (ScCas9 ∆1337-1338 or ScCas9 ∆KQ), reverted the PAM specificity to a more 
Genome Editing by ScCas9 Variants in Human Cells
We assessed the ability of ScCas9 and ScCas9 ∆Loop ∆KQ to edit mammalian genomes by co-transfecting HEK293T cells with plasmids expressing these variants along with sgRNAs directed to a native genomic locus (VEGFA) with varying PAM sequences. We first tested editing efficiency at a site containing an overlapping PAM (5'-GGGT-3'). Af- 
Genus-wide Prediction of Divergent Streptococcus Cas9 PAMs
Demonstrations of efficient genome editing by Cas9 nucleases with distinct PAM specificity from several Streptococcus species, including S. canis, motivated us to develop a bioinformatics pipeline for discovering additional Cas9 proteins with novel PAM requirements in the Streptococcus genus. We call this method the Search for PAMs by ALignment Of Targets (SPAMALOT). Briefly, we mapped a 20 nt portion of spacers flanked by known Streptococcus repeat sequences to candidate protospacers that align with no more than two mismatches in phages associated with the genus. We grouped 12 nt protospacer 3'-adjacent sequences from each alignment by genome and CRISPR repeat, and then generated group WebLogos (22) to compute presumed PAM features. Figure 4A shows that resulting WebLogos accurately reflect the known PAM specificities of Cas9 from S.
canis (this work), S. pyogenes, S. thermophilus, and S. mutans (7, 25, 26) . We identified a notable diversity in the WebLogo plots derived from various S. thermophilus cassettes with common repeat sequences ( Figure 4B ), each of which could originate from any other such S. thermophilus WebLogo upon subtle specificity changes that traverse intermediate WebLogos among them. We observe a similar relationship between two S. oralis WebLogos that also share this repeat, as well as unique putative PAM specificities associated with CRISPR cassettes containing S. mutans-like repeats from the S.oralis, S. equinis, and S. pseudopneumoniae genomes ( Figure 4C ).
Investigation of Sequence Conservation Between S. canis and Other Streptococcus Cas9 Orthologs
To further investigate the distinguishing motif insertions in ScCas9, we inserted the loop (Figure 5A) . FACS analysis on a fixed 5'-TGG-3' PAM confirmed these binding profiles, with SpCas9 ::KQ yielding half the fraction of GFP-positive cells compared to SpCas9 ( Figure   5B ). This data, in conjunction with the binding profiles of ScCas9 variants (Figure 2 ), suggests that while these insertions within ScCas9 do distinguish its PAM preference from SpCas9, other sequence features of ScCas9 also contribute to its divergence.
S. canis has been reported to infect dogs, cats, cows, and humans, and has been implicated as an adjacent evolutionary neighbor of S. pyogenes, as evidenced by various phylogenetic analyses (20, 27, 28) . In addition to sharing common hosts, we identified S. canis CRISPR spacers that map to phage lysogens in S. pyogenes genomes, which suggests they are overlapping viral hosts as well. This close evolutionary relationship has manifested itself in the sequence homology of ScCas9 and SpCas9, amongst other orthologous genes, predicted to be a result of lateral gene transfer (LGT) (20, 27, 28) .
Nonetheless, from the alignment of SpCas9 and ScCas9, the first 1240 positions score with 93.5% similarity and the last 144 positions score with 52.8%. To account for the exceptional divergence in the PAM-interacting domain (PID) at the C-terminus of ScCas9 as well as the positive-charged inserted loop, we focused on alignment of the distinguishing sequences of ScCas9 to other Streptococcus Cas9 orthologs ( Figure 5C ). Notably, the loop motif is present in certain orthologs, such as those from S. gordonii, S. anginosus, and S. intermedius, while the ScCas9 PID is mostly composed of disjoint sequences from other orthologs, such as those from S. phocae, S. varani, and S. equinis. Additional LGT events between these orthologs, as opposed to isolated divergence, more likely explain the differences between ScCas9 and SpCas9. Our demonstration that two insertion motifs in ScCas9 alter PAM preferences, yet do not abolish PAM binding when removed, suggests other functional evolutionary intermediates in the formation of effective PAM preferences.
Discussion
As the growth and development of CRISPR technologies continue, the range of targetable sequences remains limited by the requirement for a PAM sequence flanking a given target site. While significant discovery and engineering efforts have been undertaken to expand this range (9) (10) (11) (12) (13) (14) (15) , there are still only a handful of CRISPR endonucleases with minimal specificity requirements. Here, we have developed an analogous platform for genome editing using the Cas9 from Streptococcus canis, a highly-similar SpCas9 ortholog.
Established PAM engineering methods, such as random mutagenesis and directed evolution, can only generate substitution mutations in protein coding sequences. An alternative approach consists of rationally inserting or removing motifs with specific properties, which may provide a sequence search space that more common mutagenic techniques cannot directly access. Here, we have demonstrated the efficacy of this method on ScCas9, whose sequence disparities with SpCas9 include two divergent motifs. Engineered variants lacking these motifs exhibit altered PAM specificities in both bacterial and human cells. While we do observe minimal inconsistencies in PAM preference between the two assays, which may be explained by PAM-dependent allosteric changes that drive DNA cleavage (19) , the PAM divergence of ScCas9 from SpCas9 remains consistent in all tested contexts.
To date, there are no open-source tools or platforms specifically for the prediction of PAM sequences, though prior studies have conducted internal bioinformatics-based char-acterizations prior to experimental validation (9-11, 13, 25) . Here, we have established SPAMALOT as a resource that we plan to share with the community for application to CRISPR cassettes from other genera. Future development will include broadening the scope of candidate targets beyond genus-associated phage to capture additional sequences that could be beneficial targets, such as lysogens in species that host the same phage. We hope that this pipeline can be utilized to more efficiently validate and engineer PAM specificities that expand the targeting range of CRISPR, especially for strictly PAMconstrained technologies such as base editing (29) and homology repair induction (30) .
Finally, because ScCas9 does not require any alterations to the sgRNA of SpCas9, and due to its significant sequence homology with SpCas9, we presume that identical modifications from previous studies (31) (32) (33) can be made to increase the accuracy and specificity of the endonuclease and its variants, though further characterization is necessary. Overall, we anticipate that the development of a broadened Streptococcus Cas9 toolkit with expanded targeting range will enhance the current set of CRISPR technologies.
Materials and Methods
Identification of Cas9 Homologs and Generation of Plasmids
The UniProt database (16) was mined for all Streptococcus Cas9 protein sequences, which were used as inputs to either the BioPython pairwise2 module or Geneious to conduct global pairwise alignments with SpCas9, using the BLOSUM62 scoring matrix (17) , and subsequently calculate percent homology. The Cas9 from Streptococcus canis was codon optimized for E. Coli, ordered as gBlocks from Integrated DNA Technologies (IDT), and assembled using Golden Gate Assembly. Engineering of the coding sequence of ScCas9 was conducted using either the Q5 Site-Directed Mutagenesis Kit (NEB) or Gibson As-sembly. Plasmid backbones for human expression were purchased from Oxford Genetics, and manipulated to individually insert the ORFs of SpCas9, ScCas9 variants, or the sgRNA targeting sequence using Gibson or Golden Gate Assembly.
PAM-SCANR Assay
Plasmids for the SpCas9 sgRNA and PAM-SCANR genetic circuit, as well as BW25113 ∆lacI cells, were generously provided by the Beisel Lab. Plasmid libraries containing the target sequence followed by either randomized 4-bp 5'-CNNNNC-3' or fixed PAM sequences were constructed by conducting site-directed mutagenesis on the PAM-SCANR plasmid. Nuclease-deficient mutations were introduced to the Cas9 variants using Gibson Assembly. The provided BW25113 cells were made electrocompetent using standard glycerol wash and resuspension protocols. The dCas9 and sgRNA plasmids, with resistance to chloromphenicol (Chl) and carbenicillin (Crb) respectively, were co-electroporated into the electrocompetent cells at 2.4 kV, outgrown, and plated on Crb+Chl Luria Broth (LB) agar plates overnight. Individual colonies were picked, grown to ABS600 of 0.6 in Crb+Chl LB liquid media, and made electrocompetent. The PAM-SCANR plasmid, with resistance to kanamycin (Kan), was electroporated into the electrocompetent cells harboring both the dCas9 and sgRNA plasmids, outgrown, and collected in 5 mL Crb+Chl+Kan LB media. Overnight cultures were diluted to an ABS600 of 0.01 and cultured to an OD600 of 0.2. Cultures were analyzed and sorted on a FACSAria machine (Becton Dickinson).
Events were gated based on forward scatter and side scatter and fluorescence was measured in the FITC channel, with at least 30,000 gated events for data analysis. Sorted GFP-positive cells were grown to sufficient density, and plasmids from the pre-sorted and sorted populations were then isolated, and the region flanking the nucleotide library was PCR amplified and submitted for Sanger sequencing (Genewiz). Bacteria harbor-ing non-library PAM plasmids were analyzed by FACS analysis following electroporation and overnight incubation, and represented as the percent of GFP-positive cells in the population. Additional details on the PAM-SCANR assay can be found in Leenay, et al. (23) .
Cell Culture and Indel Analysis
HEK293T cells were maintained in DMEM supplemented with 100 units/ml penicillin, 100 mg/ml streptomycin, and 10% fetal bovine serum (FBS). sgRNA plasmid (500 ng) and Cas9 plasmid (500 ng) were transfected into cells (2 x 10 5 /well in a 24-well plate) with
Lipofectamine 2000 (Invitrogen) in Opti-MEM (Gibco). After 48 hours post-transfection, genomic DNA was extracted using QuickExtract Solution (Epicentre), and VEGFA loci were amplified by PCR. The T7E1 reaction was conducted according to the manufacturers instructions and equal concentration of products were analyzed on a 2% agarose gel stained with SYBR Safe (Thermo Fisher Scientific). Unprocessed gel image files were analyzed in Fiji (34) . The cleaved bands of interest were isolated using the rectangle tool, the area under the corresponding peaks were measured, averaged for each sample, and represented as ratios to the background control. Spacer sequences found within the Type II CRISPR cassettes associated with Cas9 ORFs from specified Streptococcus genomes were aligned to Streptococcus phage genomes to generate spacer-protospacer mappings. WebLogos (22) , labeled with the relevant species, genome, and CRISPR repeat, were generated for sequences found at the 3' end of candidate protospacer targets with no more than two mismatches (2mm). A) PAM predictions for experimentally validated Cas9 PAM sequences in previous studies. SPAMALOT correctly predicts the PAM of experimentally characterized Cas9 enzymes from the specified S. mutans, S. pyogenes, S. canis, and S. thermophilus genomes (7, 25, 26) . B) Novel PAM predictions of alternate S. thermophilus Cas9 orthologs with putative divergent specificities. C) Novel PAM predictions of uncharacterized Streptococcus orthologs with distinct specificities. 
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